Such companies include: Abgenix , AbTech, AERES.Biomedical, Affibody, Affimed Therapeutics, Altarex, Atopix, Avanir/Xenerex, BioInvent, Biosite, Borean, Cambridge Antibody Technology (CAT), CellTech, Centocor, Chugai, Corvas, Crucell, CYTOS Biotechnology, Dyax, EluSys Therapeutics, ESBATech, Exelixis, Genentech, GeneTastix, GenMab A/S / Medarex, Human Genome Sciences, IDEC, ILEX Oncology, ImmunoGen, ImmunoMedics, Japan Tobacco, JARI Pharmaceuticals, Kirin Brewery, KS Biomedix, Kyowa Hakko Kogyo, Lexicon Genetics, MacroGenics, MedImmune, Morphosys, Oxford Biomedica, Peregrine Pharmaceuticals, Perlan, Philogen, Procyon BioPharma, Protein Design Labs, Raven Biotechnologies, Sagres Discovery, Seattle Genetics, Symphogen, Tanox Biosystems, U3 Pharma,Viventia, XTL Biopharmaceuticals and ZymoGenetics.
Sample companies in this area include: Acadia Pharmaceuticals, ActiveX Biosciences, Archemix, Arexis, Arpida, AtherSys, AutoGen, AxCell Biosciences, Biofrontera, Caprion, CellZome, Cogent Neuroscience, Compugen, Cytomyx, deCode Genetics, DeveloGen, Digital Gene Technologies, EGEA Genomics, EOS Biotechnology, EuroProteome, Galapagos Genomics, Genaissance, Geneva Proteomics, Genicon Sciences, GenOdyssee, Glaucus Proteomics, GPC Biotech, Hibergen, Hybrigenics, Inpharmatica, Large Scale Biology, Lynx Therapeutics, MDS Proteomics, Meltec, Molecular Staging, Neogenesis, Neurome, NeuroTrophic, NextGen Sciences, Oasis Biosciences, Oxagen, Pharmagene, Phylos, Protein Pathways, Proteome Systems, Psychogenics, Quark Biotech Inc. (QBI), Rubicon Genomics, Sense Protemic, Signature Bioscience, Structural Bioinformatics Inc. (SBI), Structural GenomiX Inc. (SGI), SurroMed, Syrrx, UmanGenomics, Vita Genomics, Xenon Genetics, Zycos, and Zymogenetics.
Conversely, on the buy-side of the partnering equation, BioForesight has a long interaction history with dozens of BIG Pharma/BIG Biotech companies in Europe, North America and Japan/Asia. North American & European pharmaceutical and larger biotech companies with which we maintain regular contact include:
Abbott, Akzo Nobel / N.V. Organon, Alcon, Allergan, Amersham, Amgen / Immunex, Applied Biosystems, Ares Serono, Asta Medica, Astra-Zeneca, Aventis / Aventis Pasteur, Baxter, Bayer, Beaufour-Ipsen, BD / Becton Dickinson, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Byk Gulden / Altana, Celera, Centocor / J&J, Cephalon, Chiesi, Chiron, Dompe, Elan, Eli Lilly & Co., Ferring AB, Fournier, Genentech, Genzyme, Gilead, GSK / Glaxo-SmithKline, Gruenenthal, H. Lundbeck, Human Genome Sciences, IDEC Pharmaceuticals, Incyte, Invitrogen, Johnson & Johnson / J&J / Janssen, Ortho Biotech / R.W. Johnson Pharmaceutical Research Institute, Leo Pharmaceutical, Ligand, MedImmune, Menarini, Merck & Co. (USA), Merck KGaA , Merckle, Novartis, Novo Nordisk, Orion Farmos, Perkin-Elmer, Pfizer / Pharmacia, Pierre Fabre Medicament, Procter & Gamble Pharmaceuticals, Protein Design Labs, Purdue Pharma, Recordati, Roche Bioscience, Roche / Hoffmann La-Roche, Sanofi-Synthelabo, Schering AG, Schering-Plough, Schwarz Pharma, Servier, Shire, Sigma-Tau Farmaceutiche, Solvay, UCB Pharma, Wyeth / American Home Products and Zambon Group.
In Asia, Japanese pharmaceutical and pharma-related companies with which we maintain regular contact include:
Ajinomoto, Asahi Kasi, Banyu, Chugai, Daiichi, Dainippon, Eisai, Fujisawa, Hisamitsu, Japan Tobacco, Kaken, Kaketsuken, Kirin Brewery / Gemini Science, Kissei, Kowa, Kyorin, Kyowa Hakko Kogyo, Meiji Seika Kaisha, Mitsubishi Pharma, Mochida, Nihon Medi-Physics, Nippon Kayaku, Nippon Shinyaku, Nippon Zoki, Ono, Otsuka, Sankyo, Santen, Sanwa Kagaku, Shionogi, Sumitomo Pharmaceuticals, Sumitomo Chemical, Suntory, Taiho, Taisho, Takeda, TAP Holdings, Teijin, Toray, Toyama, Yamanouchi, Zenyaku Kogyo and Zeria.
In sum, you can rely on BioForesightıs global vision and reach to identify and access partnering, licensing and dealmaking opportunities worldwide. So donıt limit your options -- contact BioForesight today !
